CRA recently updated its 2011 review of health technology assessment (HTA) policies, and widened the assessment to cover 16 countries including emerging markets that have recently implemented HTA. Click the link below for a summary of key findings, with a link to the full report.
Navigating Payer Challenges in Rare Disease
Navigating payer challenges for rare disease treatments requires innovative approaches to evidence generation and pricing strategies. Our Life Sciences...